This Temple wants your brain, not prayers

Deepinder Goyal’s healthtech venture, Temple, has acquired Longevous, an evidence-based longevity medicine practice based in London.

What is Temple: it is a device designed to continuously measure blood flow in the brain in real time. The small gold- or silver-coloured sensor is worn near the temple and tracks cerebral blood flow, a key indicator of neurological health and ageing.

What does this mean: the deal aims to bring Longevous’ clinical expertise and research experience to work alongside Temple’s in-house science team as the company prepares for launch.

Temple is being developed under Goyal’s personal research initiative, Continue Research, to which he has committed $25 million of his own money.

Just recently, Deepinder Goyal said on X that the device is now less than half the size of what we have seen so far.

In a tweet on X, Deepinder Goyal shared…

Big theme: globally, wearable technology is increasingly moving from being a niche lifestyle accessory to a mainstream health and wellness product, particularly among fitness-conscious consumers looking to track body metrics in real time.

Global wearable device shipments totalled 145.7 million units in Q1 2026, up 4.3% YoY, according to IDC’s Worldwide Wearable Device Tracker.

Hearables remained the largest wearable category by a wide margin, accounting for roughly two-thirds of all shipments. The category spans everything from premium noise-cancelling earbuds and health-sensing devices to affordable earphones, helping attract new users while also driving repeat purchases.